A carregar...
Druggable genome in attention deficit/hyperactivity disorder and its co-morbid conditions. New avenues for treatment
Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder with only symptomatic care available. Genome-wide association (GWA) studies can provide a starting point in the search for novel drug targets and possibilities of drug repurposing. Here, we explored the druggable...
Na minha lista:
| Publicado no: | Mol Psychiatry |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group UK
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7165040/ https://ncbi.nlm.nih.gov/pubmed/31628418 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41380-019-0540-z |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|